{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:05:12Z","timestamp":1791295512783,"version":"4.1.0"},"reference-count":112,"publisher":"American Society of Hematology","issue":"20","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Most heritable anemias are caused by mutations in genes encoding globins, red blood cell (RBC) membrane proteins, or enzymes in the glycolytic and hexose monophosphate shunt pathways. A less common class of genetic anemia is caused by mutations that alter the functions of erythroid transcription factors (TFs). Many TF mutations associated with heritable anemia cause truncations or amino acid substitutions, resulting in the production of functionally altered proteins. Characterization of these mutant proteins has provided insights into mechanisms of gene expression, hematopoietic development, and human disease. Mutations within promoter or enhancer regions that disrupt TF binding to essential erythroid genes also cause anemia and heritable variations in RBC traits, such as fetal hemoglobin content. Defining the latter may have important clinical implications for de-repressing fetal hemoglobin synthesis to treat sickle cell anemia and \u03b2 thalassemia. Functionally important alterations in genes encoding TFs or their cognate cis elements are likely to occur more frequently than currently appreciated, a hypothesis that will soon be tested through ongoing genome-wide association studies and the rapidly expanding use of global genome sequencing for human diagnostics. Findings obtained through such studies of RBCs and associated diseases are likely generalizable to many human diseases and quantitative traits.<\/jats:p>","DOI":"10.1182\/blood-2014-01-453167","type":"journal-article","created":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T04:54:49Z","timestamp":1395377689000},"page":"3080-3088","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":63,"title":["Erythro-megakaryocytic transcription factors associated with hereditary anemia"],"prefix":"10.1182","volume":"123","author":[{"given":"John D.","family":"Crispino","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology, Northwestern University, Chicago, IL; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell J.","family":"Weiss","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"3","key":"2019111817422731400_B1","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1182\/blood-2007-07-098996","article-title":"EKLF restricts megakaryocytic differentiation at the benefit of erythrocytic differentiation.","volume":"112","author":"Bouilloux","year":"2008","journal-title":"Blood"},{"issue":"12","key":"2019111817422731400_B2","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2007-03-082065","article-title":"Novel role for EKLF in megakaryocyte lineage commitment.","volume":"110","author":"Frontelo","year":"2007","journal-title":"Blood"},{"issue":"13","key":"2019111817422731400_B3","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood-2013-05-468223","article-title":"Congenital dyserythropoietic anemias: molecular insights and diagnostic approach.","volume":"122","author":"Iolascon","year":"2013","journal-title":"Blood"},{"issue":"9","key":"2019111817422731400_B4","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3324\/haematol.2013.089490","article-title":"Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I.","volume":"98","author":"Babbs","year":"2013","journal-title":"Haematologica"},{"issue":"8","key":"2019111817422731400_B5","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1038\/emboj.2012.55","article-title":"Codanin-1, mutated in the anaemic disease CDAI, regulates Asf1 function in S-phase histone supply.","volume":"31","author":"Ask","year":"2012","journal-title":"EMBO J"},{"issue":"25","key":"2019111817422731400_B6","doi-asserted-by":"crossref","first-page":"6928","DOI":"10.1182\/blood-2010-09-308478","article-title":"Codanin-1 mutations in congenital dyserythropoietic anemia type 1 affect HP1alpha localization in erythroblasts.","volume":"117","author":"Renella","year":"2011","journal-title":"Blood"},{"issue":"5","key":"2019111817422731400_B7","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/bjh.12058","article-title":"Molecular mechanisms of pathology and treatment in Diamond Blackfan Anaemia.","volume":"159","author":"Horos","year":"2012","journal-title":"Br J Haematol"},{"issue":"7","key":"2019111817422731400_B8","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1172\/JCI63597","article-title":"Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia.","volume":"122","author":"Sankaran","year":"2012","journal-title":"J Clin Invest"},{"issue":"5","key":"2019111817422731400_B9","doi-asserted-by":"crossref","first-page":"a011700","DOI":"10.1101\/cshperspect.a011700","article-title":"The molecular basis of \u03b2-thalassemia.","volume":"3","author":"Thein","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"2019111817422731400_B10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semcdb.2004.11.002","article-title":"GATA1 in normal and malignant hematopoiesis.","volume":"16","author":"Crispino","year":"2005","journal-title":"Semin Cell Dev Biol"},{"issue":"11","key":"2019111817422731400_B11","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1101\/gad.4.11.1886","article-title":"Transcriptional activation and DNA binding by the erythroid factor GF-1\/NF-E1\/Eryf 1.","volume":"4","author":"Martin","year":"1990","journal-title":"Genes Dev"},{"issue":"5","key":"2019111817422731400_B12","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1128\/MCB.16.5.2238","article-title":"A palindromic regulatory site within vertebrate GATA-1 promoters requires both zinc fingers of the GATA-1 DNA-binding domain for high-affinity interaction.","volume":"16","author":"Trainor","year":"1996","journal-title":"Mol Cell Biol"},{"issue":"1","key":"2019111817422731400_B13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0092-8674(00)80318-9","article-title":"FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation.","volume":"90","author":"Tsang","year":"1997","journal-title":"Cell"},{"issue":"3","key":"2019111817422731400_B14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/73480","article-title":"Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1.","volume":"24","author":"Nichols","year":"2000","journal-title":"Nat Genet"},{"issue":"2","key":"2019111817422731400_B15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1097-2765(00)80312-3","article-title":"Use of altered specificity mutants to probe a specific protein-protein interaction in differentiation: the GATA-1:FOG complex.","volume":"3","author":"Crispino","year":"1999","journal-title":"Mol Cell"},{"issue":"2","key":"2019111817422731400_B16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000086586","article-title":"Dyserythropoietic anemia and thrombocytopenia due to a novel mutation in GATA-1.","volume":"114","author":"Del Vecchio","year":"2005","journal-title":"Acta Haematol"},{"issue":"8","key":"2019111817422731400_B17","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1182\/blood-2006-02-004101","article-title":"X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation.","volume":"109","author":"Tubman","year":"2007","journal-title":"Blood"},{"issue":"6","key":"2019111817422731400_B18","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1182\/blood-2006-06-022848","article-title":"Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria.","volume":"109","author":"Phillips","year":"2007","journal-title":"Blood"},{"issue":"2","key":"2019111817422731400_B19","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/sj.leu.2404904","article-title":"Congenital transfusion-dependent anemia and thrombocytopenia with myelodysplasia due to a recurrent GATA1(G208R) germline mutation.","volume":"22","author":"Kratz","year":"2008","journal-title":"Leukemia"},{"issue":"26","key":"2019111817422731400_B20","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1182\/blood-2013-03-488080","article-title":"Analysis of disease-causing GATA1 mutations in murine gene complementation systems.","volume":"121","author":"Campbell","year":"2013","journal-title":"Blood"},{"issue":"1","key":"2019111817422731400_B21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/bjh.12184","article-title":"A novel GATA1 mutation (Stop414Arg) in a family with the rare X-linked blood group Lu(a-b-) phenotype and mild macrothrombocytic thrombocytopenia.","volume":"161","author":"Singleton","year":"2013","journal-title":"Br J Haematol"},{"issue":"1-2","key":"2019111817422731400_B22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1615\/CritRevOncog.v16.i1-2.40","article-title":"Myeloid leukemia in Down syndrome.","volume":"16","author":"Khan","year":"2011","journal-title":"Crit Rev Oncog"},{"issue":"7","key":"2019111817422731400_B23","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/ng1825","article-title":"An inherited mutation leading to production of only the short isoform of GATA-1 is associated with impaired erythropoiesis.","volume":"38","author":"Hollanda","year":"2006","journal-title":"Nat Genet"},{"key":"2019111817422731400_B24","article-title":"Loss of GATA-1 full length as a cause of Diamond-Blackfan anemia phenotype [published online ahead of print January 22, 2014].","author":"Parrella","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"2019111817422731400_B25","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1172\/JCI63989","article-title":"What\u2019s in a name?","volume":"122","author":"Weiss","year":"2012","journal-title":"J Clin Invest"},{"issue":"2","key":"2019111817422731400_B26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/ng0695-224","article-title":"Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals.","volume":"10","author":"Tournamille","year":"1995","journal-title":"Nat Genet"},{"key":"2019111817422731400_B27","first-page":"315-319","article-title":"X-linked sideroblastic anemia due to ALAS2 intron 1 enhancer element GATA binding site mutations.","volume":"89(3)","author":"Campagna","year":"2013","journal-title":"Am J Hematol"},{"issue":"20","key":"2019111817422731400_B28","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3324\/haematol.2013.085449","article-title":"Identification of the novel erythroid-specific enhancer for ALAS2 gene and its loss-of-function mutation associated with congenital sideroblastic anemia.","volume":"99","author":"Kaneko","year":"2014","journal-title":"Haematologica"},{"issue":"6","key":"2019111817422731400_B29","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1172\/JCI10642","article-title":"Uroporphyrinogen III synthase erythroid promoter mutations in adjacent GATA1 and CP2 elements cause congenital erythropoietic porphyria.","volume":"107","author":"Solis","year":"2001","journal-title":"J Clin Invest"},{"issue":"10","key":"2019111817422731400_B30","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1182\/blood-2004-04-1603","article-title":"Global regulation of erythroid gene expression by transcription factor GATA-1.","volume":"104","author":"Welch","year":"2004","journal-title":"Blood"},{"issue":"4","key":"2019111817422731400_B31","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.molcel.2009.11.002","article-title":"Insights into GATA-1-mediated gene activation versus repression via genome-wide chromatin occupancy analysis.","volume":"36","author":"Yu","year":"2009","journal-title":"Mol Cell"},{"issue":"12","key":"2019111817422731400_B32","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1101\/gr.098921.109","article-title":"Erythroid GATA1 function revealed by genome-wide analysis of transcription factor occupancy, histone modifications, and mRNA expression.","volume":"19","author":"Cheng","year":"2009","journal-title":"Genome Res"},{"issue":"4","key":"2019111817422731400_B33","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.molcel.2009.11.001","article-title":"Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy.","volume":"36","author":"Fujiwara","year":"2009","journal-title":"Mol Cell"},{"issue":"6","key":"2019111817422731400_B34","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ng1566","article-title":"Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1.","volume":"37","author":"Li","year":"2005","journal-title":"Nat Genet"},{"issue":"18","key":"2019111817422731400_B35","doi-asserted-by":"crossref","first-page":"5250","DOI":"10.1093\/emboj\/20.18.5250","article-title":"In vivo requirements for GATA-1 functional domains during primitive and definitive erythropoiesis.","volume":"20","author":"Shimizu","year":"2001","journal-title":"EMBO J"},{"issue":"4","key":"2019111817422731400_B36","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MOH.0b013e32833a06f8","article-title":"Gfi1-cells and circuits: unraveling transcriptional networks of development and disease.","volume":"17","author":"Phelan","year":"2010","journal-title":"Curr Opin Hematol"},{"issue":"11","key":"2019111817422731400_B37","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1038\/leu.2010.195","article-title":"Gfi1 and Gfi1b: key regulators of hematopoiesis.","volume":"24","author":"van der Meer","year":"2010","journal-title":"Leukemia"},{"issue":"13","key":"2019111817422731400_B38","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1038\/sj.emboj.7600702","article-title":"GATA-1 forms distinct activating and repressive complexes in erythroid cells.","volume":"24","author":"Rodriguez","year":"2005","journal-title":"EMBO J"},{"issue":"3","key":"2019111817422731400_B39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1101\/gad.959102","article-title":"The zinc-finger proto-oncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineages.","volume":"16","author":"Saleque","year":"2002","journal-title":"Genes Dev"},{"issue":"14","key":"2019111817422731400_B40","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood-2009-09-241752","article-title":"Gfi-1B controls human erythroid and megakaryocytic differentiation by regulating TGF-beta signaling at the bipotent erythro-megakaryocytic progenitor stage.","volume":"115","author":"Randrianarison-Huetz","year":"2010","journal-title":"Blood"},{"issue":"11","key":"2019111817422731400_B41","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1111\/jth.12368","article-title":"GFI1B mutation causes a bleeding disorder with abnormal platelet function.","volume":"11","author":"Stevenson","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2019111817422731400_B42","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJMoa1308130","article-title":"A dominant-negative GFI1B mutation in the Gray platelet syndrome.","volume":"370","author":"Monteferrario","year":"2014","journal-title":"N Engl J Med"},{"issue":"5","key":"2019111817422731400_B43","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1128\/MCB.13.5.2776","article-title":"A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Kr\u00fcppel family of nuclear proteins.","volume":"13","author":"Miller","year":"1993","journal-title":"Mol Cell Biol"},{"issue":"1","key":"2019111817422731400_B44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1128\/MCB.01058-12","article-title":"EKLF\/KLF1, a tissue-restricted integrator of transcriptional control, chromatin remodeling, and lineage determination.","volume":"33","author":"Yien","year":"2013","journal-title":"Mol Cell Biol"},{"issue":"6529","key":"2019111817422731400_B45","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/375318a0","article-title":"Lethal beta-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF.","volume":"375","author":"Perkins","year":"1995","journal-title":"Nature"},{"issue":"6529","key":"2019111817422731400_B46","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/375316a0","article-title":"Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene.","volume":"375","author":"Nuez","year":"1995","journal-title":"Nature"},{"issue":"11","key":"2019111817422731400_B47","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1128\/MCB.01016-09","article-title":"EKLF directly activates the p21WAF1\/CIP1 gene by proximal promoter and novel intronic regulatory regions during erythroid differentiation.","volume":"30","author":"Siatecka","year":"2010","journal-title":"Mol Cell Biol"},{"issue":"6","key":"2019111817422731400_B48","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.exphem.2006.02.018","article-title":"Major erythrocyte membrane protein genes in EKLF-deficient mice.","volume":"34","author":"Nilson","year":"2006","journal-title":"Exp Hematol"},{"issue":"12","key":"2019111817422731400_B49","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1101\/gr.135707.111","article-title":"Novel roles for KLF1 in erythropoiesis revealed by mRNA-seq.","volume":"22","author":"Tallack","year":"2012","journal-title":"Genome Res"},{"issue":"10","key":"2019111817422731400_B50","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1073\/pnas.1121019109","article-title":"A core erythroid transcriptional network is repressed by a master regulator of myelo-lymphoid differentiation.","volume":"109","author":"Wontakal","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2019111817422731400_B51","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1182\/blood-2008-03-145672","article-title":"Mutations in EKLF\/KLF1 form the molecular basis of the rare blood group In(Lu) phenotype.","volume":"112","author":"Singleton","year":"2008","journal-title":"Blood"},{"issue":"6","key":"2019111817422731400_B52","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/MOH.0b013e328358f92e","article-title":"Blood group phenotypes resulting from mutations in erythroid transcription factors.","volume":"19","author":"Singleton","year":"2012","journal-title":"Curr Opin Hematol"},{"issue":"34","key":"2019111817422731400_B53","doi-asserted-by":"crossref","first-page":"15151","DOI":"10.1073\/pnas.1004996107","article-title":"Severe anemia in the Nan mutant mouse caused by sequence-selective disruption of erythroid Kruppel-like factor.","volume":"107","author":"Siatecka","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2019111817422731400_B54","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ygeno.2010.07.009","article-title":"Mutation in erythroid specific transcription factor KLF1 causes Hereditary Spherocytosis in the Nan hemolytic anemia mouse model.","volume":"96","author":"Heruth","year":"2010","journal-title":"Genomics"},{"key":"2019111817422731400_B55","first-page":"68","article-title":"Dominant haemolytic anaemia.","volume":"68","author":"Lyon","year":"1993","journal-title":"Mouse News Lett"},{"issue":"5","key":"2019111817422731400_B56","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ajhg.2010.10.010","article-title":"A dominant mutation in the gene encoding the erythroid transcription factor KLF1 causes a congenital dyserythropoietic anemia.","volume":"87","author":"Arnaud","year":"2010","journal-title":"Am J Hum Genet"},{"issue":"10","key":"2019111817422731400_B57","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1182\/blood-2013-09-526087","article-title":"Mutations in Kruppel-like factor 1 cause transfusion-dependent hemolytic anemia and persistence of embryonic globin gene expression.","volume":"123","author":"Viprakasit","year":"2014","journal-title":"Blood"},{"issue":"11","key":"2019111817422731400_B58","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1182\/blood-2011-04-349985","article-title":"Mutations in the second zinc finger of human EKLF reduce promoter affinity but give rise to benign and disease phenotypes.","volume":"118","author":"Singleton","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2019111817422731400_B59","doi-asserted-by":"crossref","first-page":"a011643","DOI":"10.1101\/cshperspect.a011643","article-title":"The switch from fetal to adult hemoglobin.","volume":"3","author":"Sankaran","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"9","key":"2019111817422731400_B60","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/ng.630","article-title":"Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin.","volume":"42","author":"Borg","year":"2010","journal-title":"Nat Genet"},{"issue":"10","key":"2019111817422731400_B61","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/ng2108","article-title":"A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15.","volume":"39","author":"Menzel","year":"2007","journal-title":"Nat Genet"},{"issue":"33","key":"2019111817422731400_B62","doi-asserted-by":"crossref","first-page":"11869","DOI":"10.1073\/pnas.0804799105","article-title":"DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.","volume":"105","author":"Lettre","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2019111817422731400_B63","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1073\/pnas.0711566105","article-title":"Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia.","volume":"105","author":"Uda","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5909","key":"2019111817422731400_B64","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1126\/science.1165409","article-title":"Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A.","volume":"322","author":"Sankaran","year":"2008","journal-title":"Science"},{"issue":"7259","key":"2019111817422731400_B65","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/nature08243","article-title":"Developmental and species-divergent globin switching are driven by BCL11A.","volume":"460","author":"Sankaran","year":"2009","journal-title":"Nature"},{"issue":"9","key":"2019111817422731400_B66","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/ng.637","article-title":"KLF1 regulates BCL11A expression and gamma- to beta-globin gene switching.","volume":"42","author":"Zhou","year":"2010","journal-title":"Nat Genet"},{"issue":"10","key":"2019111817422731400_B67","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1182\/blood-2010-08-300723","article-title":"Therapeutic levels of fetal hemoglobin in erythroid progeny of \u03b2-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer.","volume":"117","author":"Wilber","year":"2011","journal-title":"Blood"},{"issue":"6058","key":"2019111817422731400_B68","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1126\/science.1211053","article-title":"Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing.","volume":"334","author":"Xu","year":"2011","journal-title":"Science"},{"issue":"6513","key":"2019111817422731400_B69","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/373432a0","article-title":"Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1\/SCL.","volume":"373","author":"Shivdasani","year":"1995","journal-title":"Nature"},{"issue":"15","key":"2019111817422731400_B70","doi-asserted-by":"crossref","first-page":"7075","DOI":"10.1073\/pnas.92.15.7075","article-title":"Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene.","volume":"92","author":"Robb","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6922","key":"2019111817422731400_B71","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature01345","article-title":"Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL\/tal-1 gene.","volume":"421","author":"Mikkola","year":"2003","journal-title":"Nature"},{"issue":"3","key":"2019111817422731400_B72","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1073\/pnas.0237324100","article-title":"The critical regulator of embryonic hematopoiesis, SCL, is vital in the adult for megakaryopoiesis, erythropoiesis, and lineage choice in CFU-S12.","volume":"100","author":"Hall","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"2019111817422731400_B73","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1093\/emboj\/16.11.3145","article-title":"The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1\/NLI proteins.","volume":"16","author":"Wadman","year":"1997","journal-title":"EMBO J"},{"issue":"47","key":"2019111817422731400_B74","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1038\/sj.onc.1210766","article-title":"Mechanisms of transcription factor deregulation in lymphoid cell transformation.","volume":"26","author":"O\u2019Neil","year":"2007","journal-title":"Oncogene"},{"issue":"13","key":"2019111817422731400_B75","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1093\/nar\/gks281","article-title":"Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies.","volume":"40","author":"Bresnick","year":"2012","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2019111817422731400_B76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2011.04.007","article-title":"The role of the GATA2 transcription factor in normal and malignant hematopoiesis.","volume":"82","author":"Vicente","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6494","key":"2019111817422731400_B77","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/371221a0","article-title":"An early haematopoietic defect in mice lacking the transcription factor GATA-2.","volume":"371","author":"Tsai","year":"1994","journal-title":"Nature"},{"issue":"7","key":"2019111817422731400_B78","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1084\/jem.20031556","article-title":"GATA-2 plays two functionally distinct roles during the ontogeny of hematopoietic stem cells.","volume":"200","author":"Ling","year":"2004","journal-title":"J Exp Med"},{"issue":"10","key":"2019111817422731400_B79","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/ng.913","article-title":"Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia.","volume":"43","author":"Hahn","year":"2011","journal-title":"Nat Genet"},{"issue":"10","key":"2019111817422731400_B80","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood-2011-05-356352","article-title":"Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome.","volume":"118","author":"Hsu","year":"2011","journal-title":"Blood"},{"issue":"10","key":"2019111817422731400_B81","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/ng.923","article-title":"Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome).","volume":"43","author":"Ostergaard","year":"2011","journal-title":"Nat Genet"},{"issue":"6","key":"2019111817422731400_B82","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1101\/gad.7.6.1097","article-title":"Ectopic expression of a conditional GATA-2\/estrogen receptor chimera arrests erythroid differentiation in a hormone-dependent manner.","volume":"7","author":"Briegel","year":"1993","journal-title":"Genes Dev"},{"issue":"14","key":"2019111817422731400_B83","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1101\/gad.13.14.1847","article-title":"A GATA-2\/estrogen receptor chimera functions as a ligand-dependent negative regulator of self-renewal.","volume":"13","author":"Heyworth","year":"1999","journal-title":"Genes Dev"},{"issue":"15","key":"2019111817422731400_B84","doi-asserted-by":"crossref","first-page":"8811","DOI":"10.1073\/pnas.1432147100","article-title":"GATA-1-dependent transcriptional repression of GATA-2 via disruption of positive autoregulation and domain-wide chromatin remodeling.","volume":"100","author":"Grass","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2019111817422731400_B85","doi-asserted-by":"crossref","first-page":"e1001103","DOI":"10.1371\/journal.pgen.1001103","article-title":"A single cis element maintains repression of the key developmental regulator Gata2.","volume":"6","author":"Snow","year":"2010","journal-title":"PLoS Genet"},{"issue":"21","key":"2019111817422731400_B86","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1242\/dev.080440","article-title":"Combinatorial regulation of tissue specification by GATA and FOG factors.","volume":"139","author":"Chlon","year":"2012","journal-title":"Development"},{"issue":"8","key":"2019111817422731400_B87","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1101\/gad.12.8.1176","article-title":"Failure of megakaryopoiesis and arrested erythropoiesis in mice lacking the GATA-1 transcriptional cofactor FOG.","volume":"12","author":"Tsang","year":"1998","journal-title":"Genes Dev"},{"issue":"24","key":"2019111817422731400_B88","doi-asserted-by":"crossref","first-page":"14030","DOI":"10.1073\/pnas.1936250100","article-title":"Endothelial lineage-mediated loss of the GATA cofactor Friend of GATA 1 impairs cardiac development.","volume":"100","author":"Katz","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2019111817422731400_B89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tig.2013.10.001","article-title":"Ldb1 complexes: the new master regulators of erythroid gene transcription.","volume":"30","author":"Love","year":"2014","journal-title":"Trends Genet"},{"issue":"6422","key":"2019111817422731400_B90","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/362722a0","article-title":"Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein.","volume":"362","author":"Andrews","year":"1993","journal-title":"Nature"},{"issue":"4","key":"2019111817422731400_B91","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1357-2725(97)00135-0","article-title":"The NF-E2 transcription factor.","volume":"30","author":"Andrews","year":"1998","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"2019111817422731400_B92","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2141.2005.05416.x","article-title":"Gene expression profiling in polycythaemia vera: overexpression of transcription factor NF-E2.","volume":"129","author":"Goerttler","year":"2005","journal-title":"Br J Haematol"},{"issue":"2","key":"2019111817422731400_B93","doi-asserted-by":"crossref","first-page":"112","DOI":"10.5966\/sctm.2012-0046","article-title":"Elevated nuclear factor erythroid-2 levels promote epo-independent erythroid maturation and recapitulate the hematopoietic stem cell and common myeloid progenitor expansion observed in polycythemia vera patients.","volume":"2","author":"Bogeska","year":"2013","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"2019111817422731400_B94","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20110540","article-title":"A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2.","volume":"209","author":"Kaufmann","year":"2012","journal-title":"J Exp Med"},{"issue":"5","key":"2019111817422731400_B95","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1084\/jem.20120521","article-title":"MPN patients harbor recurrent truncating mutations in transcription factor NF-E2.","volume":"210","author":"Jutzi","year":"2013","journal-title":"J Exp Med"},{"issue":"5","key":"2019111817422731400_B96","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0092-8674(95)90531-6","article-title":"Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin\/MGDF in megakaryocyte development.","volume":"81","author":"Shivdasani","year":"1995","journal-title":"Cell"},{"issue":"19","key":"2019111817422731400_B97","doi-asserted-by":"crossref","first-page":"8690","DOI":"10.1073\/pnas.92.19.8690","article-title":"Erythropoiesis and globin gene expression in mice lacking the transcription factor NF-E2.","volume":"92","author":"Shivdasani","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2019111817422731400_B98","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1073\/pnas.93.8.3514","article-title":"Complexity of the erythroid transcription factor NF-E2 as revealed by gene targeting of the mouse p18 NF-E2 locus.","volume":"93","author":"Kotkow","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2019111817422731400_B99","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/ng.405","article-title":"Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II.","volume":"41","author":"Schwarz","year":"2009","journal-title":"Nat Genet"},{"issue":"29","key":"2019111817422731400_B100","doi-asserted-by":"crossref","first-page":"E2001","DOI":"10.1073\/pnas.1209207109","article-title":"SEC23B is required for the maintenance of murine professional secretory tissues.","volume":"109","author":"Tao","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2019111817422731400_B101","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.tig.2008.06.001","article-title":"Revealing the architecture of gene regulation: the promise of eQTL studies.","volume":"24","author":"Gilad","year":"2008","journal-title":"Trends Genet"},{"issue":"7429","key":"2019111817422731400_B102","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nature11677","article-title":"Seventy-five genetic loci influencing the human red blood cell.","volume":"492","author":"van der Harst","year":"2012","journal-title":"Nature"},{"issue":"4","key":"2019111817422731400_B103","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2141.2009.07650.x","article-title":"Discovering the genetics underlying foetal haemoglobin production in adults.","volume":"145","author":"Thein","year":"2009","journal-title":"Br J Haematol"},{"issue":"6155","key":"2019111817422731400_B104","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1126\/science.1242088","article-title":"An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level.","volume":"342","author":"Bauer","year":"2013","journal-title":"Science"},{"issue":"7","key":"2019111817422731400_B105","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","article-title":"ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering.","volume":"31","author":"Gaj","year":"2013","journal-title":"Trends Biotechnol"},{"issue":"18","key":"2019111817422731400_B106","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1101\/gad.197020.112","article-title":"Cyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and number.","volume":"26","author":"Sankaran","year":"2012","journal-title":"Genes Dev"},{"issue":"22","key":"2019111817422731400_B107","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1182\/blood-2013-07-460337","article-title":"Applications of high-throughput DNA sequencing to benign hematology.","volume":"122","author":"Sankaran","year":"2013","journal-title":"Blood"},{"issue":"4","key":"2019111817422731400_B108","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.cell.2013.04.025","article-title":"One-step generation of mice carrying mutations in multiple genes by CRISPR\/Cas-mediated genome engineering.","volume":"153","author":"Wang","year":"2013","journal-title":"Cell"},{"issue":"7414","key":"2019111817422731400_B109","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome.","volume":"489","author":"Bernstein","year":"2012","journal-title":"Nature"},{"issue":"4","key":"2019111817422731400_B110","doi-asserted-by":"crossref","first-page":"e1001046","DOI":"10.1371\/journal.pbio.1001046","article-title":"A user\u2019s guide to the encyclopedia of DNA elements (ENCODE).","volume":"9","author":"Consortium","year":"2011","journal-title":"PLoS Biol"},{"issue":"12","key":"2019111817422731400_B111","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1101\/gr.158261.113","article-title":"Integrating and mining the chromatin landscape of cell-type specificity using self-organizing maps.","volume":"23","author":"Mortazavi","year":"2013","journal-title":"Genome Res"},{"issue":"1","key":"2019111817422731400_B112","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1172\/JCI21197","article-title":"FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau\/Jacobsen thrombopenia.","volume":"114","author":"Raslova","year":"2004","journal-title":"J Clin Invest"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/123\/20\/3080\/1376160\/3080.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/123\/20\/3080\/1376160\/3080.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T07:02:34Z","timestamp":1716620554000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/123\/20\/3080\/32681\/Erythromegakaryocytic-transcription-factors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,15]]},"references-count":112,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2014,5,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2014-01-453167","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,15]]}}}